Inequity and the Interstitium: Pushing Back on Disparities in Fibrosing Lung Disease in the United States and Canada
- PMID: 35007493
- PMCID: PMC8886941
- DOI: 10.1164/rccm.202111-2652ED
Inequity and the Interstitium: Pushing Back on Disparities in Fibrosing Lung Disease in the United States and Canada
Comment on
-
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.Am J Respir Crit Care Med. 2022 Feb 15;205(4):459-467. doi: 10.1164/rccm.202109-2065OC. Am J Respir Crit Care Med. 2022. PMID: 34818133
Similar articles
-
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.Am J Respir Crit Care Med. 2022 Feb 15;205(4):459-467. doi: 10.1164/rccm.202109-2065OC. Am J Respir Crit Care Med. 2022. PMID: 34818133
-
Unexplained health inequality--is it unfair?Int J Equity Health. 2015 Jan 31;14:11. doi: 10.1186/s12939-015-0138-2. Int J Equity Health. 2015. PMID: 25637028 Free PMC article.
-
Chronic lung disease-related mortality in the US from 1999-2017: trends and racial disparities.J Perinatol. 2022 Sep;42(9):1244-1245. doi: 10.1038/s41372-022-01468-5. Epub 2022 Jul 29. J Perinatol. 2022. PMID: 35906284 No abstract available.
-
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity.Rheum Dis Clin North Am. 2020 Nov;46(4):685-692. doi: 10.1016/j.rdc.2020.07.005. Epub 2020 Sep 9. Rheum Dis Clin North Am. 2020. PMID: 32981645 Review.
-
Socioeconomic Disparities in Women's Cardiovascular Health in the United States and Canada.Can J Cardiol. 2024 Jun;40(6):1056-1068. doi: 10.1016/j.cjca.2024.04.001. Epub 2024 Apr 7. Can J Cardiol. 2024. PMID: 38593915 Review.
Cited by
-
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review.Eur Respir Rev. 2025 Apr 2;34(176):240176. doi: 10.1183/16000617.0176-2024. Print 2025 Apr. Eur Respir Rev. 2025. PMID: 40174956 Free PMC article. Review.
References
-
- Goobie GC, Ryerson CJ, Johannson KA, Schikowski E, Zou RH, Khalil N, et al. Neighborhood-level disadvantage impacts on patients with fibrotic interstitial lung disease. Am J Respir Crit Care Med . 2022;205:459–467. - PubMed
-
- George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez FJ, et al. Erice ILD working group Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med . 2020;8:925–934. - PubMed
-
- Johannson KA, Chaudhuri N, Adegunsoye A, Wolters PJ. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet . 2021;398:1450–1460. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical